Sancilio & Company Announces the Expansion of Its Pharmaceutical Laboratories Into a New Facility in Palm Beach Gardens, Florida

RIVIERA BEACH, FL--(Marketwire - March 25, 2009) -

Today Sancilio & Company, Inc. announced the expansion of its pharmaceutical laboratories into a new facility in Palm Beach Gardens, Florida. The new facility will allow expansion of SCI’s development capabilities and provide adequate workspace for planned expansion during 2009.

Dr. Fred D. Sancilio, SCI’s President, stated, “We are very fortunate to have found and relocated our laboratories into this new building at this time. We are in the process of launching several new products and services, and frankly the former laboratories were simply too small to house the number of scientists needed to support these pharmaceutical products. We expect to double our scientific staff by the end of the year, and this facility will allow this to happen.”

The new facility will house the companies analytical and development teams, and be equipped with High Performance Liquid Chromatography, Gas Chromatography, Mass Spectrophotometer, Fourier Transform Infrared Analyzer, and a variety of other scientific apparatus used in pharmaceutical development. Additionally, the new building will house ICH stability chambers with installed generator back-up electrical power systems.

SCI has developed three products indicated for the prevention of dental caries in children, three additional products to treat essential fatty acid deficiency in adults and two sterile formulations that will be submitted to the US FDA for approval by year’s end. One of these two sterile products has been licensed to a multinational pharmaceutical company in exchange for milestone and royalty payments.

About Sancilio & Company, Inc. (SCI)

SCI is a pharmaceutical development company focused on products that maintain or improve health. The senior management, which consists of veteran scientists, possess an average of over 25 years of pharmaceutical experience. The company operates under US Food and Drug laws and is registered with FDA, DEA and state regulatory agencies, complying with all state and federal laws. Products are developed and manufactured in state of the art Laboratories and cGMP manufacturing facilities located in Palm Beach County, Florida. SCI also operates a contract research organization helping domestic and foreign pharmaceutical companies bring new medicine to a global market.

To obtain more information, please contact Sherri Adams, Director of Sales at 561.741.6500 ext. 114 or at sherria@sancilio.com. Please visit our website at www.sancilio.com.